Risk factors of postoperative delayed wound healing in patients with rheumatoid arthritis treated with a biological agent
Sign Up to like & getrecommendations! Published in 2020 at "Modern Rheumatology"
DOI: 10.1080/14397595.2020.1790138
Abstract: Abstract Objectives This retrospective study aimed to investigate the risk factors associated with delayed wound healing (DWH) after orthopedic surgery in rheumatoid arthritis (RA) patients treated with biological disease-modifying antirheumatic drugs (bDMARDs). Methods We reviewed… read more here.
Keywords: wound healing; risk; risk factors; treated biological ... See more keywords
Evolution of COVID‐19 infection in 4 psoriatic patients treated with biological drugs
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.16587
Abstract: Abstract Since December 2019, the pandemic coronavirus disease (2019‐nCoV; COVID‐19) has changed the approach to all dermatological diseases; in particular, psoriatic patients undergoing immunosuppressive drugs, such as biologics, can potentially show an increase risk of… read more here.
Keywords: patients treated; psoriatic patients; treated biological; infection psoriatic ... See more keywords
Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting
Sign Up to like & getrecommendations! Published in 2021 at "Healthcare"
DOI: 10.3390/healthcare9040401
Abstract: The BNT162b2 and mRNA-1273 vaccines, consisting of mRNA, have recently become available. The absolute novelty of these vaccines introduces questions about their safety and efficacy, especially in patients who are treated with biological drugs in… read more here.
Keywords: patients treated; safety efficacy; safety; efficacy ... See more keywords